Treatment prospects for autosomal-dominant polycystic kidney disease

Slides:



Advertisements
Similar presentations
Lipid Transport Lipoproteins –Chylomicrons –VLDL = very-low-density lipoproteins –LDL = low-density lipoproteins –HDL = high-density lipoproteins Copyright.
Advertisements

The Lipids: Triglycerides, Phospholipids and Sterols.
Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
Eicosapentaenoic Acid Eicosapentaenoic acid Eicosapentaenoic acid (EPA) is an omega-3 fatty acid.
Lipids.
17.2 Fatty Acids We might think of saturated fatty acids as chips with regular shapes that stack closely together in a can. Similarly, irregularly shaped.
Hepatocyte growth factor in renal failure: Promise and reality
Volume 29, Issue 1, Pages 1-7 (January 2013)
William S. Harris, Michael Miller, Ann P. Tighe, Michael H
The PKD1 and PKD2 gene products are integral transmembrane proteins
Examples of Unsaturated Fatty Acids
Volume 34, Issue 2, Pages (April 2015)
The Ob protein (leptin) and the kidney
Current status of end-stage renal disease care in India and Pakistan
Lipids of Physiological Significance
Fatty Acids: The Basics
Chemical structure of the saccharolipid lipid A as found in E. Coli
Midterm -as per course syllabus
Hepatocyte growth factor in renal failure: Promise and reality
Matthew Spite, Joan Clària, Charles N. Serhan  Cell Metabolism 
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease 
Volume 65, Issue 5, Pages (May 2004)
Association between n-3 polyunsaturated fatty acid content of red blood cells and inflammatory biomarkers in patients with peripheral artery disease 
Toll-like receptor activation: from renal inflammation to fibrosis
Current status of end-stage renal disease care in India and Pakistan
Innate immunity as a driving force in renal disease
Comparative effects of an acute dose of fish oil on omega-3 fatty acid levels in red blood cells versus plasma: Implications for clinical utility  William.
Volume 59, Issue 1, Pages (January 2001)
Volume 58, Issue 1, Pages (July 2000)
Bioorganic Lipids 4/6/2019 Dr Seemal Jelani Chem-160.
Wnt/β-catenin signaling and kidney fibrosis
Volume 84, Issue 2, Pages (August 2013)
S. Van Biervliet, J.P. Van Biervliet, E. Robberecht, A. Christophe 
Tally Naveh-Many, Justin Silver  Kidney International 
Molecular pathogenesis of ADPKD: The polycystin complex gets complex
Gregory B. Vanden Heuvel  Kidney International 
Volume 70, Issue 11, Pages (December 2006)
Noel S. Murcia, William E. Sweeney, Ellis D. Avner 
Volume 71, Issue 11, Pages (June 2007)
Volume 73, Issue 1, Pages 5-7 (January 2008)
Florian Lang, Michael Föller  Kidney International 
Airong Li, Sonia Davila, Laszlo Furu, Qi Qian, Xin Tian, Patrick S
Pieter Evenepoel, Björn K. Meijers  Kidney International 
Cell Membranes: The Lipid Perspective
Autosomal dominant polycystic kidney disease: the last 3 years
Vladimir Lizunov, Petr Chlanda, Mary Kraft, Joshua Zimmerberg 
Volume 22, Issue 6, Pages (June 2012)
Adenosine A2A agonists as therapy for glomerulonephritis
Volume 69, Issue 12, Pages (June 2006)
Factors that Mediate and Modulate Androgen Action
EMT and proteinuria as progression factors
A possible mechanism of renal cell death after ischemia/reperfusion
Volume 69, Issue 11, Pages (June 2006)
Volume 57, Issue 1, Pages (January 2000)
Fish oil for prevention of sudden death in hemodialysis patients?
Endothelial cell activation
Volume 69, Issue 5, Pages (March 2006)
Volume 80, Issue 10, Pages (November 2011)
Cellular iron metabolism
Tobias B. Huber, Gerd Walz, E Wolfgang Kuehn  Kidney International 
Immunoregulatory role of TNFα in inflammatory kidney diseases
Is complement a target for therapy in renal disease?
Gene targeting: Applications in transplantation research
Volume 72, Issue 11, Pages (December 2007)
Hisataka Kobayashi, Peter L. Choyke  Kidney International 
T cells and T-cell receptors in acute renal failure
Alternatively activated macrophages as therapeutic agents for kidney disease: in vivo stability is a key factor  Senthilkumar Alagesan, Matthew D. Griffin 
Novel aspects of complement in kidney injury
Bioorganic Lipids 12/5/2019 Dr Seemal Jelani Chem-160.
Presentation transcript:

Treatment prospects for autosomal-dominant polycystic kidney disease Qi Qian, Peter C. Harris, Vicente E. Torres  Kidney International  Volume 59, Issue 6, Pages 2005-2022 (June 2001) DOI: 10.1046/j.1523-1755.2001.00716.x Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 1 Schematic representation of the interaction between focal adhesions, adherens complexes, Wnt signaling, and mislocalization of growth factor receptors. Hypothetical up-regulation and down-regulation of these systems in polycystic kidney disease (PKD) are depicted by arrows within circles. Kidney International 2001 59, 2005-2022DOI: (10.1046/j.1523-1755.2001.00716.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 2 Schematic representation of pathogenetic events and treatment strategies in PKD. Pathogenetic events are shown in shaded boxes, and treatment strategies are shown in open boxes. Kidney International 2001 59, 2005-2022DOI: (10.1046/j.1523-1755.2001.00716.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 3 Schematic representation of the interaction of hormones, growth factors and cytokines, retinoids, and cell–cell and cell–matrix interactions and of their signaling pathways in renal tubular epithelial cells. Signaling molecules known to be altered in PKD are shown in shaded boxes. Multiple steps of these signaling pathways can be targeted for intervention. Kidney International 2001 59, 2005-2022DOI: (10.1046/j.1523-1755.2001.00716.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 4 Schematic representation of the metabolism of omega-3 and omega-6 fatty acids. The carbon at the methyl group is referred to as the ɷ-carbon. ɷ-3 Fatty acids (FAs) have a double bond between the third and fourth carbon from the ɷ-carbon (ɷ-3 or n-3). ɷ-6 FAs have a double bond between the sixth and the seventh carbon from the ɷ-carbon (ɷ-6 or n-6). The ɷ-3 α-linolenic (LNA) and the ɷ-6 linoleic (LA) acids are essential FAs. Their metabolism involves increases in chain length and degree of unsaturation by the addition of extra double bonds. There is competition between the ɷ-3 and ɷ-6 FAs for the desaturases. LNA is converted to eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). LA is converted to arachidonic acid (AA). The metabolites derived from EPA are less inflammatory and chemotactic than those derived from AA. Soy protein feeding decreases the hepatic activity of Δ-6 desaturase. Fish oil is a rich source of EPA and DHA. Rose and Connolly discuss more about the ɷ-3 fatty acids60. Kidney International 2001 59, 2005-2022DOI: (10.1046/j.1523-1755.2001.00716.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 5 Schematic representation of an ErbB receptor, different types, and their ligands. The numbers in the boxes represent the percentage homology to the corresponding domains of ErbB-1. Reproduced by permission from Klapper et al67. Kidney International 2001 59, 2005-2022DOI: (10.1046/j.1523-1755.2001.00716.x) Copyright © 2001 International Society of Nephrology Terms and Conditions

Figure 6 Post-translational modifications of Ras required for its attachment to the plasma membrane, which is a prerequisite for its activation. Kidney International 2001 59, 2005-2022DOI: (10.1046/j.1523-1755.2001.00716.x) Copyright © 2001 International Society of Nephrology Terms and Conditions